Electrical therapies in heart failure: evolving technologies and indications

Presse Med. 2023 Oct 26:104192. doi: 10.1016/j.lpm.2023.104192. Online ahead of print.ABSTRACTDevice therapy for heart failure has rapidly evolved over 2 decades. Theknowledge of indications, assessment lead and device technology has expanded to include CRT, leadless pacing and conduction system pacing such as His bundle and left bundle branch area pacing. But there is still a lack of evidence for these new technologies as well as for common indications such as atrial fibrillation and upgrading from a previous device. The role of personlized medicine will become increasingly important when selecting candidates for CRT, primary preventive ICD ablation procedures and emrging new devices such as cardiac contractility modulation (CCM). Rapidity of therapy is associated with outcome which will be a challenge. If properly implemented devices and drugs will have a large positive affect of HF outcoomes.PMID:37898311 | DOI:10.1016/j.lpm.2023.104192
Source: Presse Medicale - Category: General Medicine Authors: Source Type: research